Determination of dosage requirements of warfarin in Iranian patients using HPLC technique

J Clin Pharm Ther. 1998 Jun;23(3):199-202. doi: 10.1046/j.1365-2710.1998.00151.x.

Abstract

In this study the warfarin level in the plasma of 60 patients receiving different dosage regimens of warfarin were determined by HPLC. The corresponding prothrombin times (PT) were also measured. The steady state plasma level of warfarin in 10 healthy volunteers was 900.7+/-158.21 ng/ml. A mean dose of 3.79+/-1.02 mg of warfarin corresponded to a therapeutic level of 1193.81+/-300.35 ng/ml with a mean PT of 20.13+/-0.69 s. The results of this study suggest that Iranian subjects are more sensitive to warfarin than North American and European subjects, but have responses very similar to those of Asians. Dietary, ethnic and geographical factors as well as differences in drug dispensition may be the cause of the observed dosage variability of warfarin.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Asia
  • Cardiovascular Diseases / drug therapy
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • Europe
  • Female
  • Humans
  • Iran
  • Male
  • Middle Aged
  • North America
  • Prothrombin Time
  • Warfarin / administration & dosage*
  • Warfarin / blood

Substances

  • Warfarin